`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.goyv
`
` APPLICATION NO.
`
`ATTORNEY DOCKFT NO.
`
`CONFIRMATION NO.
`
`046905/554252
`
`1082
`
`17/260,664
`
`ISSUE DATE
`
`03/08/2022
`
`PATENT NO.
`
`11266345
`
`826
`
`7590
`
`02/16/2022
`
`ALSTON & BIRD LLP
`ONE SOUTH AT THE PLAZA
`101 SOUTH TRYON STREET
`SUITE 4000
`CIIARLOTTE, NC 28280-4000
`
`ISSUE NOTIFICATION
`
`The projected patent number andissue date are specified above.
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustmentonthe front page.
`
`If a Continued Prosecution Application (CPA) wasfiled in the above-identified application, the filing date that
`determines Patent Term Adjustmentis the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEBsite (http://pair-uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office
`of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments
`should be directed to the Application Assistance Unit (AAU) of the Office of Data Management (ODM)at
`(571)-272-4200.
`
`INVENTOR(s) (Please see PAIR WEBsite http://pair.uspto.gov for additional inventors):
`
`Guennadi SAIKO, Mississauga, CANADA;
`Kenneth MACKO,Toronto, CANADA;
`Andrei BEI'LEN, Pickering, CANADA;
`
`APPLICANT(s) (Please see PAIR WEBsite http://pair-uspto.gov for additional applicants):
`
`Swift Medical Inc., Toronto, CANADA;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USAis the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA. gov.
`IR103 (Rev. 10/09)
`
`Petitioner's Exhibit 1002
`Page 1 of 384
`
`Petitioner's Exhibit 1002
`Page 1 of 384
`
`

`

`PART B - FEE(S) TRANSMITTAL
`
`By tax, send to:
`
`(571)-273-2885
`
`Complete and send this form, together with applicable fee(s), by mail or fax, or via EFS-Web.
`By mail, send to:
`Mail Stop ISSUE FEE
`Commissionerfor Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`INSTRUCTIONS: This form should be usedfor transmitting the ISSUE FEE and PUBLICATIONFEE(if required). Blocks | through 5 should be completed where appropriate. All
`further correspondenceincluding the Patent, advanceorders and notification of maintenancefees will be mailedto the current correspondence addressas indicated unless corrected
`below or dirccted othcrwisc in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS"for maintenance fec notifications.
`Note: A certificate of mailing can only be used for domestic mailings of the
`Fee(s) Transmittal. This certificate cannot be used for any other accompanying
`papers. Each additional paper, such as an assignment or formal drawing, must
`have its owncertificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby cerlify that this Fee(s) Transmittal is being deposiled with the Uniled
`Stales Postal Service with sufficient postage for first class mail in an envelope
`addressed lo the Mail Stop ISSUE FEE address above, or being transmilled to
`the USPTO via EFS-Webor by facsimile to (571) 273-2885, on the date below.
`(Typed orprinted name}
`Signature)
`
`CURRENT CORRESPONDENCE ADDRESS(Note: Use Block | for any change of address)
`
`11/03/2021
`
`7590
`826
`ALSTON & BIRD LLP
`ONE SOUTH AT THE PLAZA
`101 SOUTH TRYON STREET
`SUITE 4000
`CHARLOTTE, NC 28280-4000
`
`(Datei
`
` APPLICATION NO.
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKETNO.
`
`CONFIRMATION NO.
`
`Guennadi SAIKO
`
`046905/554252
`
`1082
`
`17/260,664
`
`FILING DATE
`
`01/15/2021
`
`TITLE OF INVENTION: APPARATUS TOR VISUALIZATION OF TISSUE
`
`
`
`
`
`
`
`APPLN. TYPE PUBLICATION FEE DUE|PREV. PAID ISSUE FEEENTITY STATUS ISSUE FEE DUE TOTAL FEE(S) DUE DATE DUE
`
`
`
`
`
`nonprovisional
`
`UNDISCOUNTED
`
`$1200
`
`$0.00
`
`$0.00
`
`02/03/2022
`
` EXAMINER
`
`ABOUELELA, MAY A
`
`3791
`
`600-306000
`
`ARTUNIT
`
`CLASS-SUBCLASS
`
`1. Change of correspondence addressor indication of "Fee Address" (37
`CFR 1.363).
`
`| Changeof correspondence address (or Change of Correspondence
`Address form PTO/SB/122) attached.
`
` (I “Fee Address”indication (or "Fee Address" Indication form PTO/
`
`
`
`2. For printing on the patent front page,list
`Alston & Bird LLP
`(1) The namesof up to 3 registered patent attorneys
`or agents OR,alternatively, Vo
`(2) The nameof a single firm (having as a member a
`wo
`registered attorney or agent) and the namesof up to
`2 registered patent attorneys or agents. If no nameis
`listed, no name will be printed.
`
`Ga
`
`SB/47; Rev 03-09 or more recent) attached. Use of a Customer
`Numberis required.
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT(printor lype)
`PLEASE NOTE:Unless an assignee is identified below, no assignee dala will appear onthe patent. If an assigneeis identified below, the document must have been previously
`recorded, or filed for recordation, as sel forth in 37 CFR 3.11 and 37 CFR 3.81(a). Completion of this form is NOT a substitute for filing an assignment.
`(A) NAMEOF ASSIGNEE
`(B) RESIDENCE:(CITY and STATE OR COUNTRY)
`
`Toronto, CANADA
`Swift Medical Inc.
`Please check the appropriate assignee category or categories (will not he printed on the patent) : I Individual XY Corporation or other private group entity I Government
`4a. Fees submitted:
`Kitssue Fee
`(lpublication Fee (if required)
`(JAdvance Order- # of Copies
`4b. Method of Payment: (Please first reapply any previously paidfee shown above)
`XY Electronic Payment via EFS-Web
`(LI Enclosed check
`(I Non-electronic paymentby credit card (Attach form PTO-2038)
`XI The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any overpayment to Deposit Account No. 160605
`
`5. Change in Entity Status (from status indicated above)
`NOTE:Absenta valid certification of Micro Entity Status (see forms PTO/SB/15A and 15B), issue
`| Applicant certifying micro entity status. See 37 CFR 1.29
`fee paymentin the micro entity amountwill not be acceptedatthe risk of application abandonment.
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`| Applicant asserting small entity status. See 37 CFR 1.27
`to be a notification of loss of entitlement to micro entity status.
`
`NOTE:Checking this box will be taken to be a notification of loss of entitlement to small or micro
`| Applicant changing to regular undiscounted fee status.
`entity status, as applicable.
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`_/ChristopherP. Lightner/
`Date
`2022-01-19
`
`Typed orprinted name Christopher P. Lightner
`Registration No.
`62156
`
`Authorized Signature
`
`PTOL-85 Part B (08-18) Approved for use through 01/31/2020
`
`Page 2 of 3
`OMB0651-0033
`
`USS. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`Petitioner's Exhibit 1002
`Page 2 of 384
`
`
`
`Petitioner's Exhibit 1002
`Page 2 of 384
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`17260664
`
`15-Jan-2021
`
`Title of Invention:
`
`APPARATUS FORVISUALIZATION OFTISSUE
`
`First Named Inventor/Applicant Name:
`
`Guennadi SAIKO
`
`Christopher Patrick Lightner/Grace Caffey
`
`Attorney Docket Number:
`
`046905/554252
`
`Filed as Large Entity
`
`Filing Fees for U.S. National Stage under 35 USC 371
`
`
`
`
`
`
`
`UTILITY APPL ISSUE FEE
`
`Sub-Total in
`Fee Code Quantity AmountDescription USD(S)
`
`
`
`Basic Filing:
`
`Miscellaneous-Filing:
`
`Petition:
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`
`Petitioner's Exhibit 1002
`Page 3 of 384
`
`Petitioner's Exhibit 1002
`Page 3 of 384
`
`

`

`Extension-of-Time:
`
`Miscellaneous:
`
`1200
`
`Total in USD ($)
`
`Petitioner's Exhibit 1002
`Page 4 of 384
`
`Petitioner's Exhibit 1002
`Page 4 of 384
`
`

`

`Electronic AcknowledgementReceipt
`
`eC
`
`ea
`
`
`
`Title of Invention:
`
`APPARATUS FORVISUALIZATION OFTISSUE
`
`First Named Inventor/Applicant Name:
`
`Guennadi SAIKO
`
`Customer Number:a
`ee
`
`U.S. National Stage under 35 USC 371
`Application Type:
`
`
`Paymentinformation:
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Petitioner's Exhibit 1002
`Page 5 of 384
`
`Petitioner's Exhibit 1002
`Page 5 of 384
`
`

`

`
`
`Pages
`Multi
`File Size(Bytes)/
`Document Description
`Document
`
`
`
`Number Message Digest|Part/.zip|P (if appl.)
`117163
`
`
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new applicationis being filed and the application includes the necessary componentsfor a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`Acknowledgement Receiptwill establish thefiling date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptanceof the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`NewInternational Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary componentsfor
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shown onthis Acknowledgement Receiptwill establish the international filing date of
`
`Information:
`
`Issue Fee Payment (PTO-858B)
`
`2022-01-19_554252IssueFeePa
`yment.pdf
`
`02756699c70e27268ecaed9c729a53a98a5|
`a07fe
`
`1
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`9ddf68aSacc570205 18922b273acc4a194¢}
`a893e
`
`Information:
`
`Total Files Size (in bytes)
`
`154914
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`Petitioner's Exhibit 1002
`Page 6 of 384
`
`Petitioner's Exhibit 1002
`Page 6 of 384
`
`

`

`DocuSign Envelope ID: DCDE4317-400A-4229-A2DB-CO9D7CF/69D7
`
`Attorney Docket: 046905/554252
`
`
`DECLARATION(37 CFR 1.63) FOR UTILITY OR DESIGN
`APPLICATION USING AN APPLICATION DATA SHEET (37 CFR 1.76
`
`
`Title of
`Invention
`
`APPARATUSFOR VISUALIZATION OF TISSUE
`
`Asthe below namedinventor, I hereby declare that:
`
`This declaration is directed to:
`
`| The attached application, or
`
`Xx]
`
`United States application or PCT international application number 17/260,664
`filed on January 15, 2021.
`
`The above-identified application was made or authorized to be made by me.
`
`I believe that I am the original inventor or an original joint inventor of a claimed
`invention in the application.
`
`[hereby acknowledgethat any willful false statement made in this declaration is
`punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than five (5) years, or
`both.
`
`[hereby state that I have reviewed and understand the contents of the above-identified
`specification, including the claims, as amended by any amendmentreferred to above.
`
`I acknowledge the duty to disclose information whichis material to patentability as
`defined in 37 CFR 1.56, including for continuation-in-part applications, material information
`which became available between the filmg date of the prior application and the national or PCT
`internationalfiling date of the continuation-in-part application.
`
`available,
`
`WARNING:Petitioner/applicant is cautioned to avoid submitting personal information in documents filed in a patent application that may
`contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card numbers (other than a
`check or credit card authorization form PTO-2038 submitted for payment purposes) is never required by the USPTO to support a petition or an
`application. If this type of personal information is included in documents submitted to the USPTO,petitioners/applicants should consider
`redacting such personal information from the documents before submitting them to the USPTO. Petitioner/applicant is advised that the record
`of a patent application is available to the public after publication of the application (unless a non-publication request in compliance with 37 CFR
`1.213(a) is made in the application) or issuance of a patent. Furthermore, the record from an abandonedapplication may also be available to the
`public if the application is referenced in a published application or an issued patent (sec 37 CFR 1.14). Checks and credit card authorization
`forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly
`
`LEGAL NAMEOF INVENTOR
`
`Canada
`Citizenship:
`Inventor: Guennadi SAIKO sopecntignodng
`Eunnadi Saiko
`
`
`Signature: / _/_Date (Optional):
`ET ERT
`
`
`
`Note: An application data sheet (PTO/SB/14 or equivalent), including naming the entire inventive entity, must
`accompany this form. Use an additional PTO/AIA/01 form for each additional inventor.
`
`LEGAL02/40362977v1
`
`Petitioner's Exhibit 1002
`Page 7 of 384
`
`Petitioner's Exhibit 1002
`Page 7 of 384
`
`

`

`DocuSign Envelope ID: DCDE4317-400A-4229-A2DB-CO9D7CF/69D7
`
`Attorney Docket: 046905/554252
`
`
`DECLARATION(37 CFR 1.63) FOR UTILITY OR DESIGN
`APPLICATION USING AN APPLICATION DATA SHEET (37 CFR 1.76
`
`
`Title of
`Invention
`
`APPARATUSFOR VISUALIZATION OF TISSUE
`
`Asthe below namedinventor, I hereby declare that:
`
`This declaration is directed to:
`
`| The attached application, or
`
`Xx]
`
`United States application or PCT international application number 17/260,664
`filed on January 15, 2021.
`
`The above-identified application was made or authorized to be made by me.
`
`I believe that I am the original inventor or an original joint inventor of a claimed
`invention in the application.
`
`[hereby acknowledgethat any willful false statement made in this declaration is
`punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than five (5) years, or
`both.
`
`[hereby state that I have reviewed and understand the contents of the above-identified
`specification, including the claims, as amended by any amendmentreferred to above.
`
`I acknowledge the duty to disclose information whichis material to patentability as
`defined in 37 CFR 1.56, including for continuation-in-part applications, material information
`which became available between the filmg date of the prior application and the national or PCT
`internationalfiling date of the continuation-in-part application.
`
`available,
`
`WARNING:Petitioner/applicant is cautioned to avoid submitting personal information in documents filed in a patent application that may
`contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card numbers (other than a
`check or credit card authorization form PTO-2038 submitted for payment purposes) is never required by the USPTO to support a petition or an
`application. If this type of personal information is included in documents submitted to the USPTO,petitioners/applicants should consider
`redacting such personal information from the documents before submitting them to the USPTO. Petitioner/applicant is advised that the record
`of a patent application is available to the public after publication of the application (unless a non-publication request in compliance with 37 CFR
`1.213(a) is made in the application) or issuance of a patent. Furthermore, the record from an abandonedapplication may also be available to the
`public if the application is referenced in a published application or an issued patent (sec 37 CFR 1.14). Checks and credit card authorization
`forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly
`
`LEGAL NAME OF INVENTOR
`
`Inventor: Kenneth MACKO awDovuSignedby
`Signature: /
`Reams Mache
`
`/.
`
`
`
`
`d
`
`canaca
`Citizenship:
`Date (Optional):
`
`Note: An application data sheet (PTO/SB/14 or equivalent), including naming the entire inventive entity, must
`accompany this form. Use an additional PTO/AIA/01 form for each additional inventor.
`
`LEGAL02/40362977v1
`
`Petitioner's Exhibit 1002
`Page 8 of 384
`
`Petitioner's Exhibit 1002
`Page 8 of 384
`
`

`

`DocuSign Envelope ID: DCDE4317-400A-4229-A2DB-CO9D7CF/69D7
`
`Attorney Docket: 046905/554252
`
`
`DECLARATION(37 CFR 1.63) FOR UTILITY OR DESIGN
`APPLICATION USING AN APPLICATION DATA SHEET (37 CFR 1.76
`
`
`Title of
`Invention
`
`APPARATUSFOR VISUALIZATION OF TISSUE
`
`Asthe below namedinventor, I hereby declare that:
`
`This declaration is directed to:
`
`| The attached application, or
`
`Xx]
`
`United States application or PCT international application number 17/260,664
`filed on January 15, 2021.
`
`The above-identified application was made or authorized to be made by me.
`
`I believe that I am the original inventor or an original joint inventor of a claimed
`invention in the application.
`
`[hereby acknowledgethat any willful false statement made in this declaration is
`punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than five (5) years, or
`both.
`
`[hereby state that I have reviewed and understand the contents of the above-identified
`specification, including the claims, as amended by any amendmentreferred to above.
`
`I acknowledge the duty to disclose information whichis material to patentability as
`defined in 37 CFR 1.56, including for continuation-in-part applications, material information
`which became available between the filmg date of the prior application and the national or PCT
`internationalfiling date of the continuation-in-part application.
`
`available,
`
`WARNING:Petitioner/applicant is cautioned to avoid submitting personal information in documents filed in a patent application that may
`contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card numbers (other than a
`check or credit card authorization form PTO-2038 submitted for payment purposes) is never required by the USPTO to support a petition or an
`application. If this type of personal information is included in documents submitted to the USPTO,petitioners/applicants should consider
`redacting such personal information from the documents before submitting them to the USPTO. Petitioner/applicant is advised that the record
`of a patent application is available to the public after publication of the application (unless a non-publication request in compliance with 37 CFR
`1.213(a) is made in the application) or issuance of a patent. Furthermore, the record from an abandonedapplication may also be available to the
`public if the application is referenced in a published application or an issued patent (sec 37 CFR 1.14). Checks and credit card authorization
`forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly
`
`LEGAL NAMEOF INVENTOR
`
`Inventor: Andrei BETLEN
`Citizenship: canada
`Date (Optional):
`
`Signature: /
`
`ory BocuSigned by:
`
`Note: An application data sheet (PTO/SB/14 or equivalent), including naming the entire inventive entity, must
`accompany this form. Use an additional PTO/AIA/01 form for each additional inventor.
`
`LEGAL02/40362977v1
`
`Petitioner's Exhibit 1002
`Page 9 of 384
`
`Petitioner's Exhibit 1002
`Page 9 of 384
`
`

`

`Electronic AcknowledgementReceipt
`
`oe
`
`Title of Invention:
`
`APPARATUS FORVISUALIZATION OFTISSUE
`
`First Named Inventor/Applicant Name:
`
`Guennadi SAIKO
`
`Customer Number:
`
`826
`
`Christopher Patrick Lightner/Grace Caffey
`
`Filer Authorized By:
`
`Christopher Patrick Lightner
`
`Attorney Docket Number:
`
`046905/554252
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`18-JAN-2022
`
`15-JAN-2021
`
`ea
`
`13:36:58
`
`
`
`Application Type: U.S. National Stage under 35 USC 371
`
`Paymentinformation:
`
`Submitted with Payment
`
`(if appl.) 174562
`
`Pages
`Multi
`File Size(Bytes)/
`Document Description
`Document
`
`Number Message Digest|Part /.zip|P
`
`
`1
`
`2022-01-18_554252Declaration
`s.pdf
`
`Odce20eb2Uc46b1982aa8b2bad9e873ea13}
`fic!
`
`Petitioner's Exhibit 1002
`Page 10 of 384
`
`Petitioner's Exhibit 1002
`Page 10 of 384
`
`

`

`
`
`Information:
`
`Multipart Description/PDF files in .zip description
`
`DocumentDescription
`
`Oath or Declaration filed pf
`
`Oath or Declaration filed
`
`
`
`New Applications Under 35 U.S.C. 111
`If a new applicationis being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`Acknowledgement Receiptwill establish thefiling date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptanceof the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary componentsfor
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`andof the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receiptwill establish the international filing date of
`the application.
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`Petitioner's Exhibit 1002
`Page 11 of 384
`
`Petitioner's Exhibit 1002
`Page 11 of 384
`
`

`

`PATENT
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`17/260,664
`Appl. No.:
`Applicant(s): Saiko,etal.
`Filed:
`January 15, 2021
`Art Unit:
`3791
`Examiner:
`Abouelela, May A.
`Title:
`APPARATUS FOR VISUALIZATION OF TISSUE
`
`Confirmation No.: 1082
`
`046905/554252
`Docket No.:
`Customer No.: 00826
`
`Submitted via EFS-Web
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`RESPONSE TO NOTIFICATION TO FLLE CORRECTED APPLICATION PAPERS
`
`In response to the Notification to File Corrected Application Papers mailed November
`
`10, 2021, please amend the above-identified application as follows:
`
`Amendments to the Drawings are reflected on page 2 of this paper and in the
`
`Replacement Sheet attached herewith.
`
`Remarksbegin on page 3 ofthis paper.
`
`An Appendix containing a single Replacement Sheet is attached following page 3 of
`
`this paper.
`
`A copy of the Notice to File Corrected Application Papers is also attached for reference.
`
`LEGAL02/41339458v1
`
`Petitioner's Exhibit 1002
`Page 12 of 384
`
`Petitioner's Exhibit 1002
`Page 12 of 384
`
`

`

`REPLACEMENT SHEET
`
`
`
`Petitioner's Exhibit 1002
`Page 13 of 384
`
`Petitioner's Exhibit 1002
`Page 13 of 384
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O, Box 1459
`Alexandria, Virginia 22313-1430
`ACWLIST gas
`
`CONFIRMATION NO.
`
`APPLICATION NO.
`
`17/260.664
`
`FILING DATE
`
`OI/15 2021
`
`FIRST NAMED [NVENTOR
`
`ATTORNEY DOCKET NO
`
`Guennadi SAIKO
`
`046905/554252
`
`1082
`
`ALSTON & BIRD LLP
`ONE SOUTH AT THE PLAZA
`101 SOUTH TRYON STREET
`SUITE4000
`CHARLOTTE, NC 28280-4000
`
`ABOUELELA, MAY A
`
`379
`
` NOTIFICATION DATE DELIVERY MODE
`11/10/2021
`ELECTRONIC
`
`
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period forreply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`usptomail@alston.com
`
`PTOL-90A (Rev, 04 07)
`
`Petitioner's Exhibit 1002
`Page 14 of 384
`
`Petitioner's Exhibit 1002
`Page 14 of 384
`
`

`

`
`
`Commissionerfor Patents
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`www.uspto.gov
`
`Application No. : 17260664
`Applicant
`: Saiko
`Filing Date : 01/15/2021
`Date Mailed : 11/10/2021
`
`NOTICE TO FILE CORRECTED APPLICATION PAPERS
`
`Notice ofAllowance Mailed
`
`This application has been accorded an Allowance Date and is being prepared for issuance.
`application, however, is incomplete for the reasons below.
`
`The
`
`Applicant is given two (2) months from the mail date of this Notice within which to respond. This
`time period for reply is extendable under 37 CFR 1.136(a) for only TWO additional MONTHS.
`
`The informalities requiring correction are indicated in the attachment(s). Ifthe informality pertains to the
`abstract, specification (including claims) or drawings,
`the informality must be corrected with an
`amendment in compliance with 37 CFR 1.121 (or, if the application is a reissue application, 37 CFR
`1.173). Such an amendment maybe filed after payment of the issue fee if limited to correction of
`informalities noted herein. See Waiver of 37 CFR 1.312 for Documents Required by the Office of Patent
`Publication, 1280 Off. Gaz. Patent Office 918 (March 23, 2004).
`In addition, if the informality is not
`corrected until after payment of the issue fee, for purposes of 35 U.S.C. 154(b)(1)(@v), “all outstanding
`requirements” will be considcred to have becn satisficd when the informality has becn corrected. A
`failure to respond within the above-identified time period will
`result
`in the application being
`ABANDONED.
`
`See attachment(s).
`
`A copy ofthis notice MUSTbe returned with the reply. Please address response to
`“Mail Stop Issue Fee, Commissionerfor Patents,
`P.O. Box 1450, Alexandria, VA 22313-1450”.
`
`/Anita Grimmage/
`Publication Branch
`Office of Data Management
`(571) 272-4200
`
`Petitioner's Exhibit 1002
`Page 15 of 384
`
`Petitioner's Exhibit 1002
`Page 15 of 384
`
`

`

`Application No._17260664
`
`Drawingsfiled: 01/15/2021
`
`IDENTIFICATION OF DRAWING DEFICIENCIES
`
`[1]MOCOUUUCOUUooo
`
`‘Toov
`
`
`
`
`
`
`
`‘There is a hole or the image thereof within the illustration. FIG(s)
`
`Theillustration is penctrated or traversed bya solid or broken linc that is not intended to be part of the
`drawing, such as a darkline caused by a flaw in the copying process. FIG(s)
`
`An ink stamp or the image thereof obscures part of the illustration. FIG(s)
`
`The drawing is marred by black smudges, oblitcrations, or fax/copicr marks (for example, speckles or dots
`in a substantial portion of the drawing). FIG(s)
`
`Figure numbers are duplicated or missing. FIG(s)
`
`Drawing sheetor figure is missing. FIG(s)
`
`Numbers, letters, or reference characters in the drawing have been crossed outorare illegibly handwritten.
`FIG(s)
`
`The character of the lines, numbers, andletters is poor. FIG(s)
`
`‘The drawing's background showsthatthe original drawing was made on graph paper or other paper with a
`pattern or decoration. FIG(s)
`
`The FIG. numberlabel is placed in a location that causes the drawing to be read upside down. FIG(s)
`
`Data, a reference number, or part of the drawing is truncated or missing, or a lead line has no reference
`number. T'IG(s)
`
`The drawing and/or the FIG. label contain(s) foreign language. FIG(s)
`
`This utility application contains a photographof a view that is capable of being illustrated as a line drawing.
`TIG(s) 8
`
`A petition under 37 CFR 1.84(a)(2) to accept color drawings has been granted, but the brief description of
`the drawings in the specification does not contain (or has not been amendedto contain) the paragraph
`required by 37 CFR 1.84(a)(2)(ii1).
`
`This reissue application contains added and/or amended drawingsthat are not labeled as “New” or
`“Amended”or “Canceled” as required by 37 CFR 1.173(b)(3). FIG(s)
`
`This Design reissue application contains a drawing that is labeled as “Canceled” but is not surrounded by
`brackets, or a drawing that is surrounded by brackets but is not labeled as “Canceled.” See 37 CFR
`1.173(b)(3). FIG(s)
`
`OTHER:
`
`COMMENTS:
`
`Petitioner's Exhibit 1002
`Page 16 of 384
`
`Petitioner's Exhibit 1002
`Page 16 of 384
`
`

`

`Electronic AcknowledgementReceipt
`
`ea
`
`ee
`
`16:36:24
`
`Title of Invention:
`
`APPARATUS FORVISUALIZATION OFTISSUE
`
`First Named Inventor/Applicant Name:
`
`Guennadi SAIKO
`
`Customer Number:
`
`826
`
`Christopher Patrick Lightner/Grace Caffey
`
`Filer Authorized By:
`
`Christopher Patrick Lightner
`
`Attorney Docket Number:
`
`046905/554252
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`10-JAN-2022
`
`15-JAN-2021
`
`
`
`Application Type: U.S. National Stage under 35 USC 371
`
`Paymentinformation:
`
`Submitted with Payment
`
`(if appl.) 273528
`
`Pages
`Multi
`File Size(Bytes)/
`Document Description
`Document
`
`Number Message Digest|Part /.zip|P
`
`
`1
`
`2022-01-10_554252ResponseN
`TFCAP.pdf
`
`5a1d9ca8049dd7 1180e10c1 14.32384al]
`.
`957bd
`
`Petitioner's Exhibit 1002
`Page 17 of 384
`
`Petitioner's Exhibit 1002
`Page 17 of 384
`
`

`

`
`
`Information:
`
`Multipart Description/PDF files in .zip description
`
`DocumentDescription pefe
`ApplicantResponsetoPre-ExamFormalitiesNotice Sf
`
`Drawings-only black and white line drawings
`
`Applicant Arguments/Remarks Made in an Amendment
`
`Drawings-onlyblackandwhitelinedrawings Sef
`
`Miscellaneous Incoming Letter
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new applicationis being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownon this
`Acknowledgement Receiptwill establish thefiling date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptanceof the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`NewInternational Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary componentsfor
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receiptwill establish the international filing date of
`
`This AcknowledgementReceipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`Petitioner's Exhibit 1002
`Page 18 of 384
`
`Petitioner's Exhibit 1002
`Page 18 of 384
`
`

`

`Appl No.: 17/260,664
`Amdt. dated January 10, 2022
`
`Amendments to the Drawings:
`
`Please amend the originally filed drawings with the attached Replacement Sheet.
`
`Applicant respectfully submits that no new matter has been introduced herewith.
`
`Instead, the
`
`Replacement Sheet merely formalizes the previously photographic nature of Figure 8, as
`
`highlighted in the received Notice. Entry of this Replacement Sheet
`
`is thus respectfully
`
`requested.
`
`LEGAL02/41339458v1
`
`Petitioner's Exhibit 1002
`Page 19 of 384
`
`Petitioner's Exhibit 1002
`Page 19 of 384
`
`

`

`Appl No.: 17/260,664
`Amdt. dated January 10, 2022
`
`REMARKS
`
`In response to the Notification to File Corrected Application Papers, please amend the
`
`originally filed drawings with the attached Replacement Sheet. Applicant respectfully submits
`
`that no new matter has been introduced herewith.
`
`Instead, the Replacement Sheet merely
`
`for